<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01848938</url>
  </required_header>
  <id_info>
    <org_study_id>VisareNorr301811</org_study_id>
    <secondary_id>JLL314561</secondary_id>
    <secondary_id>FAS2008-0952</secondary_id>
    <secondary_id>ALFVLL222081</secondary_id>
    <nct_id>NCT01848938</nct_id>
  </id_info>
  <brief_title>Treatment of Stress Urinary Incontinence Via Smartphone</brief_title>
  <official_title>Treatment of Stress Urinary Incontinence Via Smartphone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Umeå University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether treatment of stress urinary incontinence
      (SUI) via smartphone is effective.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Female urinary incontinence (UI) is very common and affects up to one fourth of grownup
      women. It may reduce quality of life for those affected and costs for society are high. The
      most common type of urinary incontinence is SUI, i.e leakage when coughing, sneezing or
      jumping.

      The recommended first line treatment is pelvic floor muscle training (PFMT)which leads to
      improvement or cure in two-thirds of patients. In addition, life style changes, such as
      weight loss when obese, smoking cessation and reduction of fluid intake if high is
      recommended.

      There is a need for new , flexible and easily accessible treatment programmes for female
      urinary incontinence. In our previous study, we compared two treatment programmes for SUI
      without face-to-face contact: one internet based and one sent by post, both based on three
      months of PFMT. In this randomized controlled trial of 250 women aged 18-70 years, we found
      highly significant improvements (p&lt;0.001) with large effect sizes (&gt;0,8)concerning primary
      outcomes (symptoms and quality of life scores) but no significant differences between groups.
      Compared with the postal group, more participants in the internet group perceived they were
      much or very much improved (40.9% vs 26.5%, p&lt;0.01, reported reduced usage of incontinence
      aids (59.5% vs 41.4%, p=0.02) and were satisfied with the treatment programme (84.8% vs
      62.9%, p&lt;0.001).

      The selling of smartphones is increasing rapidly. About 75% of all cellphones sold in Sweden
      today are smartphones. Two million adults in Sweden have a smartphone. Many smartphone owners
      have at least one health app on their phone. Exercise, diet, and weight apps are the most
      popular types.

      From our previous experience of an Internet-based programme, we have developed a treatment
      program designed for smartphone. The effect of the treatment programme will be evaluated
      after three months by comparing the effect in the &quot;smartphone group&quot; with the effect in the
      &quot;waiting group&quot;.

      Participants are consecutively recruited through our website. They answer an online screening
      survey with automated immediated response for initial screening of eligibility criteria.
      Informed consent and leakage diary (number of episodes of urinary leakage during 48 hours)
      are sent by post. After that, they answer a web questionnaire and finally they are
      interviewed by a researcher to confirm the diagnosis SUI and to ascertain that the patient is
      well informed of the study procedure.

      Women are then randomized to either of the two groups. Women in the smartphone group get a
      smartphone application for iphone or android. Follow-up after three months with a web
      questionnaire and a leakage diary. After that the waiting group get their smartphone
      application.

      We aim to recruit 120 women aged 18 and older via our website www.tät.nu. In the power
      calculation we assume that the improvement in the symptom score (ICIQ UI SF) and the QOL
      score (ICIQ luts QOL)in the smartphone group will be similar to the improvement we found in
      the postal group in our previous study. We also assume that the waiting group will improve in
      some extent.

      To detect a difference between groups, power 80%, 2-side test and significance 0,05, group
      size as follow

      ICIQ UI SF Smartphone group improves 2.9 (SD3,1) and waiting group 1,0 (SD2,0); 30 in each
      group

      ICIQ luts QOL Smartphone group improves 4.6 (SD6,7) and waiting group 2.0(SD3.0), 35 in each
      group

      PGI (patient´s global impression of improvement). 26,5% improves much or very much
      (smartphone) and 4% (waiting group):39 in each group

      We expect a drop out rate of 33% and thus need approximately 120 persons, 60 in each group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)</measure>
    <time_frame>baseline, three months</time_frame>
    <description>Three items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)</measure>
    <time_frame>baseline, three months</time_frame>
    <description>The instrument includes 19 items on the impact of the leakage. All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time). The overall score is 19-76, with higher values indicating increased impact on QOL.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Usage of Incontinence Aids</measure>
    <time_frame>three months</time_frame>
    <description>Usage of incontinence aids during the last 4 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>three months</time_frame>
    <description>A self-rated question about if the current treatment was sufficient, with three response options</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incontinence Episode Frequency (IEF)</measure>
    <time_frame>baseline, three months</time_frame>
    <description>number of incontinence episodes per week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient`s Global Impression of Improvement Scale (PGI-I)</measure>
    <time_frame>three months</time_frame>
    <description>A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from &quot;very much better&quot; to &quot;very much worse&quot;.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Female Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Smartphone treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Smartphone treatment with PFMT.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waiting list</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Waiting list for three months. They receive the smartphone application after follow-up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Smartphone treatment with PFMT</intervention_name>
    <description>A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. The treatment period is three months</description>
    <arm_group_label>Smartphone treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stress urinary incontinence

          -  leakage once a week or more often

          -  duration of symptoms for at least 6 months

          -  motivation and time to perform a 12 week long treatment with pelvic floor muscle
             training

          -  ability to read and write Swedish

          -  asset to smartphone

          -  possibility to send and receive email and asset to printer

          -  accept to be randomized to one of two groups; a treatment group or a waiting list
             group

        Exclusion Criteria:

          -  participation in our previous internet study

          -  pregnancy

          -  former incontinence surgery

          -  known malignancy in lower abdomen

          -  difficulties with passing urine

          -  visual blood in urine

          -  intermenstrual bleeding

          -  severe psychiatric diagnosis

          -  neurological disease with affection on sensibility in legs or lower abdomen

          -  urge incontinence
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Samuelsson, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Public Health and Clinical Medicine, Umeå University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Umea University</name>
      <address>
        <city>Umeå</city>
        <zip>S-90185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2013</study_first_submitted>
  <study_first_submitted_qc>May 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2013</study_first_posted>
  <results_first_submitted>October 17, 2016</results_first_submitted>
  <results_first_submitted_qc>October 17, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 9, 2016</results_first_posted>
  <last_update_submitted>February 21, 2017</last_update_submitted>
  <last_update_submitted_qc>February 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Umeå University</investigator_affiliation>
    <investigator_full_name>Eva Samuelsson</investigator_full_name>
    <investigator_title>Associate professor, General Practitioner</investigator_title>
  </responsible_party>
  <keyword>female</keyword>
  <keyword>stress urinary incontinence</keyword>
  <keyword>treatment</keyword>
  <keyword>pelvic floor muscle training</keyword>
  <keyword>smartphone</keyword>
  <keyword>internet</keyword>
  <keyword>life style</keyword>
  <keyword>eHealth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>We recruited community-dwelling women, from March 2013 to October 2014, through our website. Interested women filled out a questionnaire to determine whether they met the study criteria. Eligible women received a letter with informed consent and a 2-day leakage diary, and after returning this they also answered a web-based questionnaire.</recruitment_details>
      <pre_assignment_details>Randomisation was performed by concealing the allocations in sequentially numbered, opaque, sealed envelopes. An independent administrator generated the allocation sequence and prepared 130 envelopes. The study coordinator opened one envelope for each participant and assigned an e-mail, with materials for the corresponding study group.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Smartphone Treatment</title>
          <description>Smartphone treatment with PFMT.
Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months</description>
        </group>
        <group group_id="P2">
          <title>Waiting List</title>
          <description>Waiting list for three months. They receive the smartphone application after follow-up.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="61"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Smartphone Treatment</title>
          <description>Smartphone treatment with pelvic floor muscle training (PFMT).
Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months</description>
        </group>
        <group group_id="B2">
          <title>Waiting List</title>
          <description>Waiting list for three months. They receive the smartphone application after follow-up.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="62"/>
            <count group_id="B2" value="61"/>
            <count group_id="B3" value="123"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.8" spread="9.7"/>
                    <measurement group_id="B2" value="44.7" spread="9.1"/>
                    <measurement group_id="B3" value="44.7" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="123"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.0" spread="4.1"/>
                    <measurement group_id="B2" value="24.5" spread="4.4"/>
                    <measurement group_id="B3" value="24.2" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>non-smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Education</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&gt;=3 years at university level</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&lt;3 years at university level</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Parity</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>nulliparous</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>not nulliparous</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Regular Medication</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>on regular medication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>no regular medication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Usage of incontinence aids</title>
          <description>Usage of incontinence aids during the last 4 weeks.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Less than once a week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-3 times/week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;3 times/week, but not daily</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 aid a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than 1 aid a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)</title>
        <description>Three items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity</description>
        <time_frame>baseline, three months</time_frame>
        <population>intention-to-treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Treatment</title>
            <description>Smartphone treatment with PFMT.
Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months</description>
          </group>
          <group group_id="O2">
            <title>Waiting List</title>
            <description>Waiting list for three months. They receive the smartphone application after follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)</title>
          <description>Three items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity</description>
          <population>intention-to-treat analysis</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.1" spread="3.0"/>
                    <measurement group_id="O2" value="11.0" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 month follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0" spread="3.5"/>
                    <measurement group_id="O2" value="10.2" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>analysis between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Linear Mixed Models analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)</title>
        <description>The instrument includes 19 items on the impact of the leakage. All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time). The overall score is 19-76, with higher values indicating increased impact on QOL.</description>
        <time_frame>baseline, three months</time_frame>
        <population>intention-to-treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Treatment</title>
            <description>Smartphone treatment with PFMT.
Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months</description>
          </group>
          <group group_id="O2">
            <title>Waiting List</title>
            <description>Waiting list for three months. They receive the smartphone application after follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)</title>
          <description>The instrument includes 19 items on the impact of the leakage. All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time). The overall score is 19-76, with higher values indicating increased impact on QOL.</description>
          <population>intention-to-treat analysis</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.1" spread="6.1"/>
                    <measurement group_id="O2" value="34.8" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 month follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.8" spread="6.4"/>
                    <measurement group_id="O2" value="34.1" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>analysis between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <method>Linear Mixed Models analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Usage of Incontinence Aids</title>
        <description>Usage of incontinence aids during the last 4 weeks.</description>
        <time_frame>three months</time_frame>
        <population>intention-to-treat analysis. Missing values at follow-up were replaced with the corresponding values at baseline (i.e., no change).</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Treatment</title>
            <description>Smartphone treatment with PFMT.
Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months</description>
          </group>
          <group group_id="O2">
            <title>Waiting List</title>
            <description>Waiting list for three months. They receive the smartphone application after follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Usage of Incontinence Aids</title>
          <description>Usage of incontinence aids during the last 4 weeks.</description>
          <population>intention-to-treat analysis. Missing values at follow-up were replaced with the corresponding values at baseline (i.e., no change).</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>No use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Less than once a week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-3 times/week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;3 times/week, but not daily</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 aid a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than 1 aid a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>analysis between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.023</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction</title>
        <description>A self-rated question about if the current treatment was sufficient, with three response options</description>
        <time_frame>three months</time_frame>
        <population>Data for this outcome measure could only be collected for the smartphone treatment group.</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Treatment</title>
            <description>Smartphone treatment with PFMT.
Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months</description>
          </group>
          <group group_id="O2">
            <title>Waiting List</title>
            <description>Waiting list for three months. They receive the smartphone application after follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <description>A self-rated question about if the current treatment was sufficient, with three response options</description>
          <population>Data for this outcome measure could only be collected for the smartphone treatment group.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes, I am completely free of leakage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes, sufficient, although I am not completely free</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incontinence Episode Frequency (IEF)</title>
        <description>number of incontinence episodes per week</description>
        <time_frame>baseline, three months</time_frame>
        <population>intention-to-treat analysis. Missing values at follow-up were replaced with the corresponding values at baseline (i.e., no change).</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Treatment</title>
            <description>Smartphone treatment with PFMT.
Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months</description>
          </group>
          <group group_id="O2">
            <title>Waiting List</title>
            <description>Waiting list for three months. They receive the smartphone application after follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Incontinence Episode Frequency (IEF)</title>
          <description>number of incontinence episodes per week</description>
          <population>intention-to-treat analysis. Missing values at follow-up were replaced with the corresponding values at baseline (i.e., no change).</population>
          <units>episodes per week</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.0" lower_limit="10.5" upper_limit="28.0"/>
                    <measurement group_id="O2" value="17.5" lower_limit="10.5" upper_limit="24.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>three month follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="0" upper_limit="14"/>
                    <measurement group_id="O2" value="14" lower_limit="7" upper_limit="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>analysis between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient`s Global Impression of Improvement Scale (PGI-I)</title>
        <description>A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from “very much better” to “very much worse”.</description>
        <time_frame>three months</time_frame>
        <population>intention-to-treat analysis. Missing values at follow-up were replaced with a neutral value (i.e., no change).</population>
        <group_list>
          <group group_id="O1">
            <title>Smartphone Treatment</title>
            <description>Smartphone treatment with PFMT.
Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months</description>
          </group>
          <group group_id="O2">
            <title>Waiting List</title>
            <description>Waiting list for three months. They receive the smartphone application after follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient`s Global Impression of Improvement Scale (PGI-I)</title>
          <description>A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from “very much better” to “very much worse”.</description>
          <population>intention-to-treat analysis. Missing values at follow-up were replaced with a neutral value (i.e., no change).</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>very much better</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>much better</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>a little better</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>no change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>a little worse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>much worse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>very much worse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>analysis between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Smartphone Treatment</title>
          <description>Smartphone treatment with PFMT.
Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months</description>
        </group>
        <group group_id="E2">
          <title>Waiting List</title>
          <description>Waiting list for three months. They receive the smartphone application after follow-up.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Eva Samuelsson</name_or_title>
      <organization>Umeå University, Umeå, Sweden</organization>
      <phone>+46706966440</phone>
      <email>eva.samuelsson@umu.se</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

